Zhen Wang

22PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 07, 2026
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

|Jun 08, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic Core.

|May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase Inhibitor.

|Mar 19, 2026
Structure-Based Design of Potent and Highly Selective NUAK1 Inhibitors by Exploiting a Unique Glutamate Switch for the Prevention of Tumor Growth, Migration, and Invasion.

Shan Li, Yingao Wang, Xuechen Liu

|Jan 31, 2026
Enhancing Drug Repurposing with Consensus Docking: Discovery of Novel Discoidin Domain Receptor 1 Inhibitors.

Jochem Nelen, Lijie Zhao, Xiaojuan Song

|Jun 12, 2025
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma.

Jean Ching-Yi Tien, Yali Zhai, Rong Wu

Pageof 4

Frequent Collaborators

18 joint publications

Ke Ding

8 joint publications

Fengtao Zhou

7 joint publications

Yang Zhou

4 joint publications

Weixue Huang